Home › Peanut Hypersensitivity › Michigan
Peanut Hypersensitivity clinical trials in Michigan
6 studies for Peanut Hypersensitivity are looking for participants at sites in Michigan.
Cities in Michigan
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Respiratory Medicine Research Institute of Michigan, Ypsilanti
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- The University of Michigan: Division of Allergy and Clinical Immunology, Ann Arbor
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- The University of Michigan: Division of Allergy and Clinical Immunology, Ann Arbor
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Mary H. Weiser Food Allergy Center (MHWFAC) University of Michigan - Michigan Medicine, Ann Arbor
RecruitingPhase 1Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811Safety of MOON101 for the Treatment of Peanut Allergy
- University of Michigan, Ann Arbor
RecruitingPhase 1
Ages 4 to 55 · All sexes · Updated Jul 14, 2026 · NCT07580898From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.